← Back to Search

Joint Replacement

Triathlon PKR for Knee Replacement Surgery (PKR Trial)

N/A
Waitlist Available
Led By Paul Jacob, MD
Research Sponsored by Stryker Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-years
Awards & highlights

PKR Trial Summary

This trial is comparing the long-term effects of two different types of knee replacements.

PKR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Investigation of Clinical Performance and Patient Outcome With the Functional Knee Society Score (KSS).
Secondary outcome measures
10-years Kaplan Meier Survival Analysis

PKR Trial Design

1Treatment groups
Experimental Treatment
Group I: Triathlon PKRExperimental Treatment1 Intervention
All subjects enrolled will receive the Triathlon PKR device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Triathlon PKR
2013
N/A
~70

Find a Location

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor
77 Previous Clinical Trials
20,122 Total Patients Enrolled
Paul Jacob, MDPrincipal InvestigatorOklahoma Sports Science and Orthopaedics
Soren Toksvig-Larsen, MDPrincipal InvestigatorHassleholm Sygehus Ortopaedkirurgisk afd.

Media Library

Triathlon® Partial Knee Replacement (PKR) (Joint Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT00966979 — N/A
Knee Replacement Surgery Research Study Groups: Triathlon PKR
Knee Replacement Surgery Clinical Trial 2023: Triathlon® Partial Knee Replacement (PKR) Highlights & Side Effects. Trial Name: NCT00966979 — N/A
Triathlon® Partial Knee Replacement (PKR) (Joint Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00966979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who has the opportunity to engage in this experiment?

"This research is looking to enroll 175 individuals aged 21-75 who require a primary cemented unicompartmental knee replacement. In addition, participants must have less than 10 degrees of flexion contracture and greater than 90 degrees of flexion, preoperative mechanical alignment no more than 15 degrees varus or valgus, intact cruciate and collateral ligaments without instability, and they must sign an IRB approved informed consent form."

Answered by AI

Are there any open enrollment slots for this clinical experiment?

"Clinicaltrials.gov attests that this medical investigation is actively searching for participants, with the initial posting occurring on January 1st 2010 and a recent update conducted on July 8th 2022."

Answered by AI

Does the eligibility for this trial extend to individuals under thirty-five years of age?

"Patients that are 21 to 75 years old may join this clinical trial."

Answered by AI

What is the cap on patient enrollment for this clinical trial?

"Affirmative. The clinicaltrials.gov repository contains information that this experiment is currently seeking participants, first posted on January 1st 2010 and last amended July 8th 2022. 175 individuals will be required across 3 sites for the study."

Answered by AI
~7 spots leftby Apr 2025